The Hydrus Microstent is a revolutionary therapy used to help manage your glaucoma. It has been proven in global clinical trials to lower eye pressure, which resulted in a reduction of glaucoma medicine and, in some patients, eliminated the need for medication.1
As a second-generation Minimally Invasive Glaucoma Surgery (MIGS) device, Hydrus is designed to decrease your eye pressure and reduce or eliminate your need for glaucoma medications. The Hydrus Microstent can be implanted at the time of cataract surgery or as a stand-alone therapy.
Talk to your doctor to see if the Hydrus Microstent is right for you.
